why choose us

First received: June 22, 2023

Clinical Trial: Open Label Extension of Efgartigimod in Adults With Post-COVID-19 POTS

Study Status: Completed

Recruit Status: RECRUITING

Condition: Post-COVID Postural Orthostatic Tachycardia Syndrome Postural Orthostatic Tachycardia Syndrome

Study Type: INTERVENTIONAL


Official Title: Open-Label Extension Study to Evaluate the Long-term Safety and Efficacy of Efgartigimod in Adult Patients With Post-COVID-19 Postural Orthostatic Tachycardia Syndrome (PC-POTS) Who Completed Study AR

Brief Summary: The OLE study aims to investigate the safety, efficacy, pharmacodynamics (PD), pharmacokinetics (PK), and immunogenicity of efgartigimod in participants with post-COVID-19 postural orthostatic.

Read more